A share price of Ventyx Biosciences Inc [VTYX] is currently trading at $1.40, up 15.70%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VTYX shares have gain 12.90% over the last week, with a monthly amount glided 32.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ventyx Biosciences Inc [NASDAQ: VTYX] stock has seen the most recent analyst activity on March 12, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $16 from $7. Previously, Oppenheimer upgraded its rating to Outperform on March 12, 2024, and kept the price target unchanged to $12. On November 07, 2023, downgrade downgraded it’s rating to Equal Weight and revised its price target to $8 on the stock. Stifel downgraded its rating to a Hold but stick to its price target of $6 on November 07, 2023. Oppenheimer downgraded its rating to a Perform. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 07, 2023, and downed its price target to $6. In a note dated November 07, 2023, H.C. Wainwright downgraded an Neutral rating on this stock.
Ventyx Biosciences Inc experienced fluctuations in its stock price throughout the past year between $0.78 and $5.66. Currently, Wall Street analysts expect the stock to reach $33.86 within the next 12 months. Ventyx Biosciences Inc [NASDAQ: VTYX] shares were valued at $1.40 at the most recent close of the market. An investor can expect a potential return of 2318.57% based on the average VTYX price forecast.
Analyzing the VTYX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -0.47 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2633 points at the first support level, and at 1.1267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4733, and for the 2nd resistance point, it is at 1.5467.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ventyx Biosciences Inc [NASDAQ:VTYX] is 19.57. Also, the Quick Ratio is 19.57, while the Cash Ratio stands at 2.27.
Transactions by insiders
Recent insider trading involved Nuss John, CHIEF SCIENTIFIC OFFICER, that happened on Apr 02 ’25 when 1887.0 shares were sold. CHIEF SCIENTIFIC OFFICER, Nuss John completed a deal on Dec 27 ’24 to sell 21119.0 shares. Meanwhile, Officer Nuss John bought 21119.0 shares on Dec 27 ’24.
